Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Logue

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Bone and Mineral|February 1, 1991
Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancyW D Fraser, F C Logue, S J Gallacher, et al.
Calcified Tissue International|December 1, 1992
Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancyS J Gallacher, W D Fraser, F C Logue, et al.
Postgraduate Medical Journal|November 1, 1990
Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronateS J Gallacher, S H Ralston, F J Dryburgh, et al.
European Journal of Endocrinology|October 1, 1994
Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancyS J Gallacher, W D Fraser, O J Owens, et al.
Thorax|November 1, 1992
Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot studyS J Gallacher, J A Fenner, K Anderson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 17, 1998
Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosisW D Fraser, F C Logue, J P Christie, et al.
Clinical Endocrinology|April 1, 1990
The loss of circadian rhythm for intact parathyroid hormone and nephrogenous cyclic AMP in patients with primary hyperparathyroidismF C Logue, W D Fraser, S J Gallacher, et al.
Clinical Endocrinology|April 1, 1993
Coincidental occurrence of primary hyperparathyroidism and cancer-associated hypercalcaemia in a middle-aged manS J Gallacher, W D Fraser, M A Farquharson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
Low calcium dialysate and high-dose oral calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis patientsW M Van der Merwe, R S Rodger, A C Grant, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1993
An evaluation of bone density and turnover in premenopausal women with type 1 diabetes mellitusS J Gallacher, J A Fenner, B M Fisher, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Bone and Mineral|February 1, 1991
Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancyW D Fraser, F C Logue, S J Gallacher, et al.
Calcified Tissue International|December 1, 1992
Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancyS J Gallacher, W D Fraser, F C Logue, et al.
Postgraduate Medical Journal|November 1, 1990
Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronateS J Gallacher, S H Ralston, F J Dryburgh, et al.
European Journal of Endocrinology|October 1, 1994
Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancyS J Gallacher, W D Fraser, O J Owens, et al.
Thorax|November 1, 1992
Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot studyS J Gallacher, J A Fenner, K Anderson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 17, 1998
Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosisW D Fraser, F C Logue, J P Christie, et al.
Clinical Endocrinology|April 1, 1990
The loss of circadian rhythm for intact parathyroid hormone and nephrogenous cyclic AMP in patients with primary hyperparathyroidismF C Logue, W D Fraser, S J Gallacher, et al.
Clinical Endocrinology|April 1, 1993
Coincidental occurrence of primary hyperparathyroidism and cancer-associated hypercalcaemia in a middle-aged manS J Gallacher, W D Fraser, M A Farquharson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
Low calcium dialysate and high-dose oral calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis patientsW M Van der Merwe, R S Rodger, A C Grant, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1993
An evaluation of bone density and turnover in premenopausal women with type 1 diabetes mellitusS J Gallacher, J A Fenner, B M Fisher, et al.
Pageof 3